Literature DB >> 9015517

Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria.

P D Radloff1, J Philipps, D Hutchinson, P G Kremsner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9015517     DOI： 10.1016/s0035-9203(96)90435-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  9 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?

Authors:  Gabriele Franken; Irmela Müller-Stöver; Martha C Holtfreter; Susanne Walter; Heinz Mehlhorn; Alfons Labisch; Dieter Häussinger; Joachim Richter
Journal:  Parasitol Res       Date:  2012-02-18       Impact factor: 2.289

Review 3.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Plasmodium malariae infection in spite of previous anti-malarial medication.

Authors:  Irmela Müller-Stöver; Jaco J Verweij; Barbara Hoppenheit; Klaus Göbels; Dieter Häussinger; Joachim Richter
Journal:  Parasitol Res       Date:  2007-12-02       Impact factor: 2.289

5.  Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.

Authors:  Beatrix Huei-Yi Teo; Paul Lansdell; Valerie Smith; Marie Blaze; Debbie Nolder; Khalid B Beshir; Peter L Chiodini; Jun Cao; Anna Färnert; Colin J Sutherland
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

Review 6.  A systematic review of the clinical presentation, treatment and relapse characteristics of human Plasmodium ovale malaria.

Authors:  Mirjam Groger; Hannah S Fischer; Luzia Veletzky; Albert Lalremruata; Michael Ramharter
Journal:  Malar J       Date:  2017-03-11       Impact factor: 2.979

7.  Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.

Authors:  Henry M Staines; Rebekah Burrow; Beatrix Huei-Yi Teo; Irina Chis Ster; Peter G Kremsner; Sanjeev Krishna
Journal:  J Antimicrob Chemother       Date:  2018-03-01       Impact factor: 5.790

8.  Atovaquone Impairs Growth of Aspergillus and Fusarium Keratitis Isolates by Modulating Mitochondrial Function and Zinc Homeostasis.

Authors:  Heather L Clark; Martin S Minns; Yan Sun; Tristan de Jesus; Mahmoud G Ghannoum; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-01       Impact factor: 4.799

9.  Mixed-species Plasmodium falciparum and Plasmodium ovale malaria in a paediatric returned traveller.

Authors:  Heather Senn; Nadia Alattas; Andrea K Boggild; Shaun K Morris
Journal:  Malar J       Date:  2014-03-05       Impact factor: 2.979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.